Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Frontiers in Oncology|March 3, 2025
Are all programmed cell death protein 1 inhibitors the same?Jochen H Lorch, Stacey Stein, Martin J EdelmanCancer Management and Research|December 29, 2010
Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancerJochen H LorchSurgical Pathology Clinics|November 2, 2019
Treatment of Aggressive Thyroid CancerJulian Huang, Ethan James Harris, Jochen H LorchThe Oncologist|February 28, 2013
Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?Glenn J Hanna, Robert I Haddad, Jochen H LorchCancer Research|January 20, 2007
Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancerJochen H Lorch, Tarita O Thomas, Hans-Joachim SchmollClinical Lung Cancer|April 14, 2009
Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancerMartin J EdelmanAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2020
Prophylactic Cranial Irradiation for Small-Cell Lung Cancer: Time for a ReassessmentMartin J EdelmanClinical Lung Cancer|February 12, 2004
Gemcitabine and carboplatin regimens in advanced non-small-cell lung cancer: focus on randomized phase III trialsMartin J EdelmanClinical Advances in Hematology & Oncology : H&O|September 16, 2005
Second-line chemotherapy and beyond for non-small-cell lung cancerMartin J EdelmanSeminars in Oncology|February 7, 2006
An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancerMartin J EdelmanPageof 26